César Homero Gutiérrez-Aguirre

8PUBLICATIONS
23CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cardiovascular medicine and haematology not elsewhere classifiedRegenerative medicine (incl. stem cells)AutoimmunityTransplantation immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Nov 24, 2024
Romiplostim, low-dose rituximab and high-dose dexamethasone for newly diagnosed immune thrombocytopenia: A pilot study.

Perla R Colunga-Pedraza, Fernando De la Garza-Salazar, Héctor A Vaquera-Alfaro

|Jan 16, 2024
Graft-versus-host disease after an outpatient peripheral blood hematopoietic cell transplant using reduced-intensity conditioning: a single-center LATAM experience.

José Carlos Jaime-Pérez, Jesús Daniel Meléndez-Flores, Jorge Valdespino-Valdes

|Mar 15, 2023
Low-dose rituximab plus high-dose dexamethasone in newly diagnosed immune thrombocytopenia.

Edgar Ulises Coronado-Alejandro, Juan Pablo Martínez-Hernández, Andrés Gómez-De León

|Apr 12, 2022
High dose melphalan is an adequate preparative regimen for autologous hematopoietic stem cell transplantation in relapsed/refractory lymphoma.

José A Fernández-Gutiérrez, Oscar A Reyes-Cisneros, Mark R Litzow

|Sep 29, 2021
Autologous ATG-free hematopoietic stem cell transplantation for refractory autoimmune rheumatic diseases: a Latin American cohort.

José Carlos Jaime-Pérez, Mariana González-Treviño, Jesús D Meléndez-Flores

|May 28, 2021
Outpatient transplantation in the COVID-19 era: a single-center Latin American experience.

Perla R Colunga-Pedraza, Julia E Colunga-Pedraza, Jesús D Meléndez-Flores

Pageof 2